So says Ed Lazowska, the University of Washington computer science professor who played host and tour guide to the region’s big data lineup during the Washington Innovation Summit last week. He points to the region’s strengths in cloud computing, and a steady stream of big data achievers marching forth from the UW.
Any business owner will tell you that it takes a lot of wits, energy, know-how, and no shortage of luck to found your own company. Many people have trouble getting one company off the ground, but then there are the special few who actually manage to found or co-found two, three, or even 19 companies in their lifetimes.
Today’s grand challenge in medicine and biology is complexity, according to world-renowned systems biologist Lee Hood, who addressed the Northeastern University community on Monday in the fourth installment in the Profiles in Innovation Presidential Speaker Series.
San Diego’s Sapphire Energy and Seattle’s Institute for Systems Biology (ISB) have established a strategic partnership that is intended to significantly expand and diversify the genetic resources that Sapphire needs to commercialize algae-based biofuels.
NIGMS has also renewed funding for the NCSBs led by Arthur D. Lander, M.D., Ph.D., at the University of California, Irvine; and John D. Aitchison, Ph.D., at the Institute for Systems Biologyunder grants 2P50GM076516 and 2P50GM076547, respectively. (Note from ISB: ISB's renewal amounts to $13.7 million over five years.) The centers are exploring spatial dynamics and design principles in biology as well as the collective behavior of cells, cell differentiation and cellular responses to environmental changes.
For years, the constraining factor in genomics research was data generation. The slowdown in the process or “bottleneck” was that generating genomic data required a great deal of time, specialized expertise and money. Scientists generated and read genomic sequence letter by letter. Because data were slowly generated, researchers had plenty of time to analyze them. However, in recent years, new technologies for genome sequencing have been developed.
Antiviral responses must be tightly regulated to defend rapidly against infection while minimizing inflammatory damage. Type 1 interferons (IFN-I) are crucial mediators of antiviral responses
In March 2011, Covance’s Seattle-based Genomics Laboratory (CGL) collaborated with the Institute for Systems Biology (ISB), also based in Seattle, to collectively unravel the complex regulation of gene expression in Glioblastoma Multiforme (GBM), one of the most common and aggressive forms of brain cancer.
By Valerie Bauman, Puget Sound Business Journal --- Seattle’s biotech research nonprofits have been hiring — and not just scientists. With public research funding increasingly scarce and unpredictable, nonprofit research groups are bringing in new talent with fundraising as well as scientific skills.
